Filed: 5/12/2023ACC: 0001162044-23-000539
📋 What this filing means
ALPHACENTRIC ADVISORS LLC filed this quarterly 13F‑HR report disclosing 209 equity positions with a total reported market value of $144.91M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
209
Positions
$144.91M
Total AUM (reported)
16.12M
Total Shares
Allocation by class
COM$76.24M52.6%
COM NEW$11.98M8.3%
SHS$7.51M5.2%
1-3 YR TR BD ETF$6.33M4.4%
SPONSORED ADR$4.50M3.1%
COM CL A$4.39M3.0%
NOTE$4.34M3.0%
Portfolio Concentration
Top 3$13.81M9.5%
4–10$20.99M14.5%
11–25$28.51M19.7%
Rest$81.59M56.3%
Top 3 weight
9.5%
Top 10 weight
24.0%
Voting Authority Distribution
Total shares with voting rights: 161.02M
Sole
Full voting authority
144.91M
shares
% of voting shares90.0%
Shared
Joint voting authority
16.12M
shares
% of voting shares10.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other209
Dominant voting typeSole · 90.0% of voting shares
Institutional Holdings209
Rows:
ISHARES TR
OTRShares76.99K
TypeSH
Market value$6.33M
4.37%
Sole
6.33M
Shared
76.99K
None
0.00
NEW RESIDENTIAL INVT CORP
OTRShares491.70K
TypeSH
Market value$3.93M
2.71%
Sole
3.93M
Shared
491.70K
None
0.00
GALAPAGOS NV
OTRShares92K
TypeSH
Market value$3.55M
2.45%
Sole
3.55M
Shared
92K
None
0.00
BIOCRYST PHARMACEUTICALS INC
OTRShares419.50K
TypeSH
Market value$3.50M
2.41%
Sole
3.50M
Shared
419.50K
None
0.00
CENTENE CORP DEL
OTRShares50K
TypeSH
Market value$3.16M
2.18%
Sole
3.16M
Shared
50K
None
0.00
2SEVENTY BIO INC
OTRShares302.50K
TypeSH
Market value$3.09M
2.13%
Sole
3.09M
Shared
302.50K
None
0.00
GSK PLC
OTRShares80K
TypeSH
Market value$2.85M
1.96%
Sole
2.85M
Shared
80K
None
0.00
INVESCO QQQ TR
OTRShares8.75K
TypeSH
Market value$2.81M
1.94%
Sole
2.81M
Shared
8.75K
None
0.00
INVESCO EXCH TRADED FD TR II
OTRShares21.26K
TypeSH
Market value$2.81M
1.94%
Sole
2.81M
Shared
21.26K
None
0.00
HORIZON THERAPEUTICS PUB L
OTRShares25.50K
TypeSH
Market value$2.78M
1.92%
Sole
2.78M
Shared
25.50K
None
0.00
ELLINGTON FINANCIAL INC
OTRShares200.17K
TypeSH
Market value$2.44M
1.69%
Sole
2.44M
Shared
200.17K
None
0.00
COHERUS BIOSCIENCES INC
OTRShares354.50K
TypeSH
Market value$2.42M
1.67%
Sole
2.42M
Shared
354.50K
None
0.00
MR COOPER GROUP INC
OTRShares56.79K
TypeSH
Market value$2.33M
1.61%
Sole
2.33M
Shared
56.79K
None
0.00
HARMONY BIOSCIENCES HLDGS IN
OTRShares67.50K
TypeSH
Market value$2.20M
1.52%
Sole
2.20M
Shared
67.50K
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
OTRShares190K
TypeSH
Market value$2.09M
1.44%
Sole
2.09M
Shared
190K
None
0.00
INNOVIVA INC
OTRShares184K
TypeSH
Market value$2.07M
1.43%
Sole
2.07M
Shared
184K
None
0.00
ELANCO ANIMAL HEALTH INC
OTRShares215K
TypeSH
Market value$2.02M
1.39%
Sole
2.02M
Shared
215K
None
0.00
LANTHEUS HLDGS INC
OTRShares23K
TypeSH
Market value$1.90M
1.31%
Sole
1.90M
Shared
23K
None
0.00
MFA FINL INC
OTRShares173.43K
TypeSH
Market value$1.72M
1.19%
Sole
1.72M
Shared
173.43K
None
0.00
NEW YORK MTG TR INC
OTRShares172.08K
TypeSH
Market value$1.71M
1.18%
Sole
1.71M
Shared
172.08K
None
0.00
BIO RAD LABS INC
OTRShares3.40K
TypeSH
Market value$1.63M
1.12%
Sole
1.63M
Shared
3.40K
None
0.00
NEUROCRINE BIOSCIENCES INC
OTRShares15.50K
TypeSH
Market value$1.57M
1.08%
Sole
1.57M
Shared
15.50K
None
0.00
ADC THERAPEUTICS SA
OTRShares760K
TypeSH
Market value$1.48M
1.02%
Sole
1.48M
Shared
760K
None
0.00
PACIRA BIOSCIENCES INC
OTRShares36K
TypeSH
Market value$1.47M
1.01%
Sole
1.47M
Shared
36K
None
0.00
ADAPTHEALTH CORP
OTRShares116.50K
TypeSH
Market value$1.45M
1.00%
Sole
1.45M
Shared
116.50K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ISHARES TROTR | 1-3 YR TR BD ETF | 76.99K | SH | $6.33M 4.37% | 6.33M | 76.99K | 0.00 |
NEW RESIDENTIAL INVT CORPOTR | COM NEW | 491.70K | SH | $3.93M 2.71% | 3.93M | 491.70K | 0.00 |
GALAPAGOS NVOTR | SPON ADR | 92K | SH | $3.55M 2.45% | 3.55M | 92K | 0.00 |
BIOCRYST PHARMACEUTICALS INCOTR | COM | 419.50K | SH | $3.50M 2.41% | 3.50M | 419.50K | 0.00 |
CENTENE CORP DELOTR | COM | 50K | SH | $3.16M 2.18% | 3.16M | 50K | 0.00 |
2SEVENTY BIO INCOTR | COMMON STOCK | 302.50K | SH | $3.09M 2.13% | 3.09M | 302.50K | 0.00 |
GSK PLCOTR | SPONSORED ADR | 80K | SH | $2.85M 1.96% | 2.85M | 80K | 0.00 |
INVESCO QQQ TROTR | UNIT SER 1 | 8.75K | SH | $2.81M 1.94% | 2.81M | 8.75K | 0.00 |
INVESCO EXCH TRADED FD TR IIOTR | NASDAQ 100 ETF | 21.26K | SH | $2.81M 1.94% | 2.81M | 21.26K | 0.00 |
HORIZON THERAPEUTICS PUB LOTR | SHS | 25.50K | SH | $2.78M 1.92% | 2.78M | 25.50K | 0.00 |
ELLINGTON FINANCIAL INCOTR | COM | 200.17K | SH | $2.44M 1.69% | 2.44M | 200.17K | 0.00 |
COHERUS BIOSCIENCES INCOTR | COM | 354.50K | SH | $2.42M 1.67% | 2.42M | 354.50K | 0.00 |
MR COOPER GROUP INCOTR | COM | 56.79K | SH | $2.33M 1.61% | 2.33M | 56.79K | 0.00 |
HARMONY BIOSCIENCES HLDGS INOTR | COM | 67.50K | SH | $2.20M 1.52% | 2.20M | 67.50K | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCOTR | COM | 190K | SH | $2.09M 1.44% | 2.09M | 190K | 0.00 |
INNOVIVA INCOTR | COM | 184K | SH | $2.07M 1.43% | 2.07M | 184K | 0.00 |
ELANCO ANIMAL HEALTH INCOTR | COM | 215K | SH | $2.02M 1.39% | 2.02M | 215K | 0.00 |
LANTHEUS HLDGS INCOTR | COM | 23K | SH | $1.90M 1.31% | 1.90M | 23K | 0.00 |
MFA FINL INCOTR | COM | 173.43K | SH | $1.72M 1.19% | 1.72M | 173.43K | 0.00 |
NEW YORK MTG TR INCOTR | COM | 172.08K | SH | $1.71M 1.18% | 1.71M | 172.08K | 0.00 |
BIO RAD LABS INCOTR | CL A | 3.40K | SH | $1.63M 1.12% | 1.63M | 3.40K | 0.00 |
NEUROCRINE BIOSCIENCES INCOTR | COM | 15.50K | SH | $1.57M 1.08% | 1.57M | 15.50K | 0.00 |
ADC THERAPEUTICS SAOTR | SHS | 760K | SH | $1.48M 1.02% | 1.48M | 760K | 0.00 |
PACIRA BIOSCIENCES INCOTR | COM | 36K | SH | $1.47M 1.01% | 1.47M | 36K | 0.00 |
ADAPTHEALTH CORPOTR | COM CL A | 116.50K | SH | $1.45M 1.00% | 1.45M | 116.50K | 0.00 |
Page 1 of 9
…